Viewing Study NCT00343733

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-02-05 @ 9:07 PM
Study NCT ID: NCT00343733
Status: COMPLETED
Last Update Posted: 2014-05-09
First Post: 2006-06-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Sponsor: Cephalon
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetic peripheral neuropathy View
None postherpetic neuralgia View
None traumatic injury View
None complex regional pain syndrome View
None back pain View
None neck pain View
None fibromyalgia View
None chronic pancreatitis View
None osteoarthritis View